Corporations venture into a world of innovation at the inaugural Symposium on May 18, 2011, at the Emirates Stadium (pictured), London, UK.

London's global appeal as a cultural centre with relative tolerance, combined with its research base across the Golden Triangle, gives it access to scientific and entrepreneurial talent to capitalise on the combination of complicated technology with soft-information skills from media and other services.

As well as its 24% equity stake, Elan will have a seat on Proteostasis' board of directors and scientific advisory board, and the first right to exclusively license new drug compounds from the collaboration.

Covagen spun out of technology university ETH Zurich in 2007 with local drugs group Novartis' backing and previously raised an undisclosed amount from Novartis Venture Fund and MPH, the corporate venturing unit of Japan's Mitsubishi Tanabe Pharma (MTP) and Mitsubishi Chemical, in October 2009.

3M New Ventures, the company's corporate venturing unit, and 3M Electro & Communications Business provided the money that will help Txtr provide access to documents and books wherever they are.

Philips and NeuroNexus Technologies became minority shareholders in Sapiens as a result of their contribution to the development of the Sapiens' system and underlying technologies that stimulate the brain to treat epilepsy and other problems from Parkinson's Disease.

The lessons from the best practices are captured in the Global Corporate Venturing Best Practices and Awards supplement.

Limburg backs Q Chip and ACS Biomarker.